BR0107544A - Composição de promoção de secreção de bile - Google Patents

Composição de promoção de secreção de bile

Info

Publication number
BR0107544A
BR0107544A BR0107544-6A BR0107544A BR0107544A BR 0107544 A BR0107544 A BR 0107544A BR 0107544 A BR0107544 A BR 0107544A BR 0107544 A BR0107544 A BR 0107544A
Authority
BR
Brazil
Prior art keywords
bile secretion
composition
promotion composition
bile
secretion promotion
Prior art date
Application number
BR0107544-6A
Other languages
English (en)
Inventor
Ryuji Ueno
Makoto Suematsu
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0107544A publication Critical patent/BR0107544A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO DE PROMOçãO DE SECREçãO DE BILE". é descrita uma composição de promoção de secreção de bile compreendendo um composto 15-ceto-prostaglandina como um ingrediente ativo. A composição é útil para tratamento de um indivíduo tendo uma condição ou doença associada à secreção de bile deficiente e também para tratamento de um fígado a ser transplantado em um processo de transplante de fígado.
BR0107544-6A 2000-04-06 2001-04-05 Composição de promoção de secreção de bile BR0107544A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19489400P 2000-04-06 2000-04-06
PCT/JP2001/002938 WO2001076593A2 (en) 2000-04-06 2001-04-05 Bile secretion promoting composition a 15-keto prostaglandin

Publications (1)

Publication Number Publication Date
BR0107544A true BR0107544A (pt) 2005-01-11

Family

ID=22719290

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107544-6A BR0107544A (pt) 2000-04-06 2001-04-05 Composição de promoção de secreção de bile

Country Status (15)

Country Link
US (2) US6469062B2 (pt)
EP (1) EP1267883B1 (pt)
JP (2) JP4183943B2 (pt)
KR (1) KR100874626B1 (pt)
CN (1) CN1241570C (pt)
AR (1) AR030277A1 (pt)
AT (1) ATE433754T1 (pt)
AU (2) AU4472701A (pt)
BR (1) BR0107544A (pt)
CA (1) CA2404767C (pt)
DE (1) DE60139002D1 (pt)
MX (1) MXPA02009915A (pt)
NZ (1) NZ521784A (pt)
TW (1) TWI232750B (pt)
WO (1) WO2001076593A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2404767C (en) * 2000-04-06 2010-12-07 Sucampo Ag Bile secretion promoting composition containing a 15-keto prostaglandin
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
TWI263505B (en) * 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
CN1753680B (zh) * 2002-12-27 2010-12-08 苏坎波公司 用于治疗腹部不适的前列腺素衍生物
CA2602812C (en) * 2005-04-12 2014-11-18 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
US8815557B2 (en) * 2005-07-08 2014-08-26 University Of Chicago Compositions and methods for refolding of denatured proteins
JP5377970B2 (ja) * 2006-02-28 2013-12-25 スキャンポ・アーゲー 慢性閉塞性肺疾患を処置するための方法および組成物
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
JP6957610B2 (ja) * 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ
KR102595299B1 (ko) 2020-10-12 2023-10-26 류형준 담즙 분비 촉진 효능이 있는 식품 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58203911A (ja) * 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS6327433A (ja) 1986-07-21 1988-02-05 Teijin Ltd 肝疾患治療剤
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5076569A (en) * 1989-09-15 1991-12-31 Gootter Steven M Contoured grip for exercising the hand
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW249226B (pt) 1990-04-04 1995-06-11 Aderk Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
JPH069404A (ja) 1992-06-23 1994-01-18 Ono Pharmaceut Co Ltd 臓器移植用薬剤
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
CA2404767C (en) * 2000-04-06 2010-12-07 Sucampo Ag Bile secretion promoting composition containing a 15-keto prostaglandin

Also Published As

Publication number Publication date
EP1267883B1 (en) 2009-06-17
US20020004524A1 (en) 2002-01-10
DE60139002D1 (de) 2009-07-30
WO2001076593A2 (en) 2001-10-18
AU2001244727B2 (en) 2006-08-10
CN1241570C (zh) 2006-02-15
NZ521784A (en) 2005-04-29
KR20020087123A (ko) 2002-11-21
ATE433754T1 (de) 2009-07-15
AR030277A1 (es) 2003-08-20
EP1267883A2 (en) 2003-01-02
JP2004519412A (ja) 2004-07-02
CA2404767C (en) 2010-12-07
JP4183943B2 (ja) 2008-11-19
CA2404767A1 (en) 2001-10-18
JP5073588B2 (ja) 2012-11-14
WO2001076593A3 (en) 2002-07-11
TWI232750B (en) 2005-05-21
US20030060506A1 (en) 2003-03-27
US6469062B2 (en) 2002-10-22
MXPA02009915A (es) 2003-03-27
AU4472701A (en) 2001-10-23
JP2008291033A (ja) 2008-12-04
CN1450899A (zh) 2003-10-22
KR100874626B1 (ko) 2008-12-17

Similar Documents

Publication Publication Date Title
GB9807639D0 (en) Anti-inflammatory agents
BR0206469A (pt) Composição injetável para depósito
DK1107749T3 (da) Anvendelse af fumarsyrederivater i transplantationsmedicin
BR0210056A (pt) composições e métodos para tratamento de hiperplasia
BR0014078A (pt) Inibidores de fator xa
DE60041976D1 (de) Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
BR0110420A (pt) Agonistas muscarìnicos
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
BR9811099A (pt) Inibidores de urocinase
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
BR0314491A (pt) Composição de polpa de fruta estabilizada, composição de purê estável e método para a fabricação de composição de polpa de fruta estabilizada
BR0107544A (pt) Composição de promoção de secreção de bile
ATE367087T1 (de) Formulierungen zur behandlung von krankheiten und verfahren unter deren verwendung
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
ATE435030T1 (de) Heilung von wunden oder fibrotischen krankheiten unter verwendung von wenigstens einem agens gegen einen wachstumsfaktor
DE69932510D1 (de) Vaskularisierungsinhibitoren
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
ATE312603T1 (de) Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren
NO2019032I1 (no) Treosulfan
DE50014532D1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
ATE353671T1 (de) Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz,zur behandlung und reparation von bindegeweben in menschen und tieren
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]